Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Sonus falls after Tocosol miss

SNUS dropped $3.65 (84%) to $0.70 on 37.3 million shares on

Read the full 119 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE